NCT01279980

Brief Summary

The purpose of this study is to find out whether the use of Painbuster® (a local anaesthetic wound catheter) can be used instead of epidurals for patients having bowel surgery in an enhanced recovery programme. The investigators want to find out whether or not using this device means people need to stay in hospital for less time after surgery.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable pain

Timeline
Completed

Started Feb 2011

Typical duration for not_applicable pain

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 19, 2011

Completed
1 day until next milestone

First Posted

Study publicly available on registry

January 20, 2011

Completed
12 days until next milestone

Study Start

First participant enrolled

February 1, 2011

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2012

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2012

Completed
Last Updated

February 18, 2011

Status Verified

February 1, 2011

Enrollment Period

1.4 years

First QC Date

January 19, 2011

Last Update Submit

February 17, 2011

Conditions

Keywords

ERASLocal anaesthetic wound catheterPainbusterEpiduralcolorectal surgeryenhanced recovery program

Outcome Measures

Primary Outcomes (1)

  • Length of hospital stay

    Length of stay will be measured in days for each group.This will be determined by a set of predefined discharge criteria.

    determined on discharge from hospital

Secondary Outcomes (10)

  • Postoperative complications

    Whilst an inpatient

  • Episodes of hypotension in the postoperative period

    whilst an inpatient

  • Postoperative pain

    as an inpatient

  • Amount of postoperative IV fluid administered

    as an inpatient

  • Body composition

    Tests will be performed daily until the epidural or Painbuster® has been removed.

  • +5 more secondary outcomes

Study Arms (2)

Epidural

ACTIVE COMPARATOR

Subjects will have an epidural catheter placed to provide postoperative pain relief. This is standard care for those undergoing an enhanced recovery program.

Other: Epidural

Painbuster

ACTIVE COMPARATOR

Subjects will have a local anaesthetic wound catheter inserted into the wound at time of surgery rather than an epidural for the provision of postoperative pain relief.

Other: Local anaesthetic wound catheter

Interventions

Epidural analgesia inserted prior to surgery to stay in until at least the second postoperative day

Epidural

The catheter will be used to infuse the wound with local anaesthetic for 48 hours post op.

Also known as: Painbuster(registered trademark)
Painbuster

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • All patients who are undergoing either laparoscopic or open colorectal resection will be considered eligible for the study.

You may not qualify if:

  • Patients under 18 years of age
  • Pregnant females
  • Patients undergoing an abdominoperineal resection
  • Patients unable to understand English

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Scarborough General Hospital

Scarborough, North Yorkshire, YO126QL, United Kingdom

RECRUITING

MeSH Terms

Conditions

Pain

Interventions

Injections, Epidural

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Injections, SpinalInjectionsDrug Administration RoutesDrug TherapyTherapeutics

Study Officials

  • Eleanor R Richards, BM Medicine

    Scarborough General Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Eleanor R Richards, BM Medicine

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

January 19, 2011

First Posted

January 20, 2011

Study Start

February 1, 2011

Primary Completion

July 1, 2012

Study Completion

July 1, 2012

Last Updated

February 18, 2011

Record last verified: 2011-02

Locations